These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34337096)

  • 1. Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies.
    Khatri A; Malhotra P; Izard S; Kim A; Oppenheim M; Gautam-Goyal P; Chen T; Doan TL; Berlinrut I; Niknam N; Flannery S; Hirschwerk D; Epstein M; Farber B
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab339. PubMed ID: 34337096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study.
    Bartoszewicz M; Czaban SL; Bartoszewicz K; Kuźmiuk D; Ładny JR
    Ther Adv Infect Dis; 2023; 10():20499361231207178. PubMed ID: 37869469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing Patterns of Bloodstream Infections in the Community and Acute Care Across 2 Coronavirus Disease 2019 Epidemic Waves: A Retrospective Analysis Using Data Linkage.
    Zhu NJ; Rawson TM; Mookerjee S; Price JR; Davies F; Otter J; Aylin P; Hope R; Gilchrist M; Shersing Y; Holmes A
    Clin Infect Dis; 2022 Aug; 75(1):e1082-e1091. PubMed ID: 34596212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased rates of secondary bacterial infections, including
    DeVoe C; Segal MR; Wang L; Stanley K; Madera S; Fan J; Schouest J; Graham-Ojo R; Nichols A; Prasad PA; Ghale R; Love C; Abe-Jones Y; Kangelaris KN; Patterson SL; Yokoe DS; Langelier CR
    Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1416-1423. PubMed ID: 34486503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU: an ancillary study of the COVID-ICU study.
    Massart N; Maxime V; Fillatre P; Razazi K; Ferré A; Moine P; Legay F; Voiriot G; Amara M; Santi F; Nseir S; Marque-Juillet S; Bounab R; Barbarot N; Bruneel F; Luyt CE;
    Ann Intensive Care; 2021 Dec; 11(1):183. PubMed ID: 34952960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
    Buetti N; Ruckly S; de Montmollin E; Reignier J; Terzi N; Cohen Y; Siami S; Dupuis C; Timsit JF
    Intensive Care Med; 2021 Feb; 47(2):180-187. PubMed ID: 33506379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea.
    Lim SJ; Choi JY; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS
    Infection; 2014 Oct; 42(5):875-81. PubMed ID: 25030309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation.
    Bauer KA; Puzniak LA; Yu KC; Finelli L; Moise P; Ai C; Watts JA; Gupta V
    BMC Infect Dis; 2022 Nov; 22(1):841. PubMed ID: 36368931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Risk Factors, and Prognosis of Bloodstream Infections in COVID-19 Patients in Intensive Care: A Single-Center Observational Study.
    Kurt AF; Mete B; Urkmez S; Demirkiran O; Dumanli GY; Bozbay S; Dilken O; Karaali R; Balkan II; Saltoğlu N; Dikmen Y; Tabak F; Aygun G
    J Intensive Care Med; 2022 Oct; 37(10):1353-1362. PubMed ID: 35607286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Nosocomial Bloodstream Infections on Mortality: A Retrospective Propensity-Matched Cohort Study.
    Petersiel N; Sherman A; Paul M
    Open Forum Infect Dis; 2021 Dec; 8(12):ofab552. PubMed ID: 34888398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study.
    Palanisamy N; Vihari N; Meena DS; Kumar D; Midha N; Tak V; Sharma A; Bohra GK; Kothari N; Dutt N; Bhatia PK; Garg MK; Misra S
    BMC Infect Dis; 2021 Sep; 21(1):933. PubMed ID: 34496787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prevalance and risk factors for bloodstream infection in severe coronavirus disease 2019 (COVID-19) patients.
    Erbay K; Ozger HS; Guzel Tunccan O; Gaygısız Ü; Buyukkoruk M; Sultanova F; Yıldız M; Boyacı Dündar N; Aydoğdu M; Bozdayi G; Dizbay M
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e30. PubMed ID: 36310789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab versus anakinra in COVID-19: results from propensity score matching.
    Arcani R; Correard F; Suchon P; Kaplanski G; Jean R; Cauchois R; Leprince M; Arcani V; Seguier J; De Sainte Marie B; Andre B; Koubi M; Rossi P; Gayet S; Gobin N; Garrido V; Weiland J; Jouve E; Couderc AL; Villani P; Daumas A
    Front Immunol; 2023; 14():1185716. PubMed ID: 37304271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study.
    Pasquini Z; Barocci I; Brescini L; Candelaresi B; Castelletti S; Iencinella V; Mazzanti S; Procaccini G; Orsetti E; Pallotta F; Amadio G; Giacometti A; Tavio M; Barchiesi F
    Int J Infect Dis; 2021 Oct; 111():31-36. PubMed ID: 34416402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory therapy, risk factors and outcomes of hospital-acquired bloodstream infection in patients with severe COVID-19 pneumonia: a Spanish case-control matched multicentre study (BACTCOVID).
    Abelenda-Alonso G; Rombauts A; Gudiol C; Oriol I; Simonetti A; Coloma A; Rodríguez-Molinero A; Izquierdo E; Díaz-Brito V; Sanmartí M; Padullés A; Grau I; Ras M; Bergas A; Guillem L; Blanco-Arévalo A; Alvarez-Pouso C; Pallarés N; Videla S; Tebé C; Carratalà J
    Clin Microbiol Infect; 2021 Nov; 27(11):1685-1692. PubMed ID: 34242804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early deaths in bloodstream infections: a population-based case series.
    Kontula KS; Skogberg K; Ollgren J; Järvinen A; Lyytikäinen O
    Infect Dis (Lond); 2016; 48(5):379-85. PubMed ID: 26763410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of morbidity and mortality related to health care-associated primary bloodstream infections in neonatal intensive care units: a prospective cohort study from the SEPREVEN trial.
    Jaloustre M; Cohen R; Biran V; Decobert F; Layese R; Audureau E; Le Saché N; Chevallier M; Boukhris MR; Bolot P; Caeymaex L; Tauzin M;
    Front Pediatr; 2023; 11():1170863. PubMed ID: 37325351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
    MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough bloodstream infections in critically ill non-neutropenic patients: higher incidence and better survival than non-breakthrough infections.
    Papadimitriou-Olivgeris M; Kolonitsiou F; Solomou A; Karamouzos V; Anastassiou ED; Christofidou M; Spiliopoulou I; Fligou F; Marangos M
    J Med Microbiol; 2019 Oct; 68(10):1544-1551. PubMed ID: 31436523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.